| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 41 | 2021 | 1469 | 5.320 |
Why?
|
| Blood Vessel Prosthesis Implantation | 31 | 2023 | 1426 | 4.470 |
Why?
|
| Aortic Aneurysm, Abdominal | 18 | 2022 | 1199 | 3.670 |
Why?
|
| Lower Extremity | 24 | 2017 | 1196 | 2.480 |
Why?
|
| Ischemia | 25 | 2024 | 1893 | 2.410 |
Why?
|
| Peripheral Arterial Disease | 24 | 2024 | 1305 | 2.390 |
Why?
|
| Arterial Occlusive Diseases | 13 | 2019 | 752 | 2.300 |
Why?
|
| Limb Salvage | 20 | 2024 | 466 | 2.210 |
Why?
|
| Endovascular Procedures | 19 | 2024 | 2135 | 2.210 |
Why?
|
| Popliteal Artery | 12 | 2022 | 312 | 1.960 |
Why?
|
| Vascular Patency | 34 | 2023 | 901 | 1.880 |
Why?
|
| Blood Vessel Prosthesis | 14 | 2023 | 945 | 1.850 |
Why?
|
| Femoral Artery | 14 | 2022 | 831 | 1.630 |
Why?
|
| Graft Occlusion, Vascular | 16 | 2024 | 560 | 1.610 |
Why?
|
| Stents | 14 | 2020 | 3303 | 1.600 |
Why?
|
| Endarterectomy, Carotid | 8 | 2018 | 560 | 1.540 |
Why?
|
| Iliac Artery | 3 | 2019 | 344 | 1.210 |
Why?
|
| Angioplasty, Balloon | 4 | 2022 | 597 | 1.210 |
Why?
|
| Saphenous Vein | 10 | 2024 | 538 | 1.170 |
Why?
|
| Arteriovenous Shunt, Surgical | 9 | 2023 | 294 | 1.090 |
Why?
|
| Carotid Stenosis | 7 | 2018 | 872 | 1.020 |
Why?
|
| Leg | 9 | 2013 | 1091 | 0.990 |
Why?
|
| Veins | 15 | 2017 | 765 | 0.940 |
Why?
|
| Endoleak | 4 | 2017 | 105 | 0.910 |
Why?
|
| Aortic Diseases | 5 | 2018 | 736 | 0.870 |
Why?
|
| Peripheral Vascular Diseases | 9 | 2011 | 515 | 0.850 |
Why?
|
| Intermittent Claudication | 6 | 2016 | 305 | 0.830 |
Why?
|
| Lithotripsy | 1 | 2023 | 142 | 0.820 |
Why?
|
| Treatment Outcome | 75 | 2023 | 64947 | 0.780 |
Why?
|
| Reoperation | 20 | 2023 | 4292 | 0.770 |
Why?
|
| Time Factors | 53 | 2023 | 40133 | 0.760 |
Why?
|
| Subclavian Artery | 2 | 2019 | 133 | 0.760 |
Why?
|
| Trabeculectomy | 3 | 2017 | 174 | 0.670 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2019 | 143 | 0.640 |
Why?
|
| Device Removal | 3 | 2021 | 634 | 0.630 |
Why?
|
| Carotid Body Tumor | 1 | 2018 | 34 | 0.610 |
Why?
|
| Carotid Artery Diseases | 3 | 2014 | 881 | 0.590 |
Why?
|
| Gonioscopy | 2 | 2017 | 155 | 0.580 |
Why?
|
| Vascular Fistula | 2 | 2020 | 50 | 0.550 |
Why?
|
| Dissection | 1 | 2018 | 298 | 0.540 |
Why?
|
| Patient Readmission | 5 | 2014 | 3327 | 0.530 |
Why?
|
| Exfoliation Syndrome | 1 | 2017 | 113 | 0.520 |
Why?
|
| Intestinal Fistula | 2 | 2020 | 143 | 0.520 |
Why?
|
| Postoperative Complications | 22 | 2022 | 15680 | 0.520 |
Why?
|
| Sclera | 1 | 2017 | 190 | 0.510 |
Why?
|
| Intraoperative Care | 1 | 2019 | 768 | 0.510 |
Why?
|
| Inguinal Canal | 3 | 2005 | 72 | 0.510 |
Why?
|
| Embolization, Therapeutic | 2 | 2023 | 1411 | 0.500 |
Why?
|
| Models, Economic | 4 | 2016 | 719 | 0.500 |
Why?
|
| Aortography | 6 | 2018 | 419 | 0.490 |
Why?
|
| Aged | 89 | 2024 | 168995 | 0.490 |
Why?
|
| Laser Therapy | 3 | 2017 | 1089 | 0.470 |
Why?
|
| Renal Dialysis | 8 | 2023 | 1802 | 0.460 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2015 | 693 | 0.460 |
Why?
|
| Retrospective Studies | 54 | 2024 | 80301 | 0.450 |
Why?
|
| Deglutition Disorders | 1 | 2019 | 627 | 0.450 |
Why?
|
| Foot Ulcer | 1 | 2014 | 63 | 0.450 |
Why?
|
| Health Care Costs | 5 | 2016 | 3257 | 0.440 |
Why?
|
| Emergencies | 1 | 2019 | 1217 | 0.420 |
Why?
|
| Aorta | 3 | 2021 | 2042 | 0.420 |
Why?
|
| Risk Factors | 45 | 2024 | 74269 | 0.420 |
Why?
|
| Kaplan-Meier Estimate | 14 | 2017 | 6545 | 0.420 |
Why?
|
| Radial Artery | 4 | 2022 | 196 | 0.410 |
Why?
|
| Length of Stay | 8 | 2021 | 6472 | 0.410 |
Why?
|
| Risk Assessment | 28 | 2023 | 24086 | 0.410 |
Why?
|
| Iliac Aneurysm | 1 | 2012 | 37 | 0.390 |
Why?
|
| Male | 99 | 2024 | 359413 | 0.390 |
Why?
|
| Aged, 80 and over | 38 | 2024 | 58947 | 0.390 |
Why?
|
| Hospital Costs | 2 | 2014 | 976 | 0.360 |
Why?
|
| Prosthesis-Related Infections | 3 | 2022 | 486 | 0.360 |
Why?
|
| Humans | 130 | 2024 | 760261 | 0.360 |
Why?
|
| Visual Acuity | 4 | 2017 | 2635 | 0.360 |
Why?
|
| Multivariate Analysis | 18 | 2017 | 12156 | 0.350 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2017 | 734 | 0.350 |
Why?
|
| Middle Aged | 67 | 2024 | 220175 | 0.350 |
Why?
|
| Specialties, Surgical | 1 | 2015 | 389 | 0.350 |
Why?
|
| Foot | 1 | 2014 | 573 | 0.350 |
Why?
|
| Female | 92 | 2024 | 391011 | 0.340 |
Why?
|
| Angioplasty | 3 | 2021 | 360 | 0.330 |
Why?
|
| Aneurysm | 2 | 2010 | 337 | 0.330 |
Why?
|
| Workload | 2 | 2020 | 846 | 0.330 |
Why?
|
| Ultrasonography, Doppler, Duplex | 8 | 2024 | 200 | 0.330 |
Why?
|
| Education, Medical, Graduate | 2 | 2014 | 2359 | 0.330 |
Why?
|
| Patient Selection | 10 | 2018 | 4276 | 0.320 |
Why?
|
| Venous Thrombosis | 2 | 2009 | 1293 | 0.310 |
Why?
|
| Vision Disorders | 1 | 2016 | 1084 | 0.310 |
Why?
|
| Markov Chains | 5 | 2016 | 971 | 0.310 |
Why?
|
| Proportional Hazards Models | 15 | 2017 | 12532 | 0.300 |
Why?
|
| Prosthesis Design | 7 | 2023 | 2127 | 0.300 |
Why?
|
| Chi-Square Distribution | 9 | 2017 | 3466 | 0.300 |
Why?
|
| Polytetrafluoroethylene | 2 | 2023 | 245 | 0.300 |
Why?
|
| Wound Healing | 10 | 2017 | 2786 | 0.280 |
Why?
|
| Registries | 11 | 2021 | 8449 | 0.280 |
Why?
|
| Laser Coagulation | 4 | 2012 | 327 | 0.280 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3598 | 0.270 |
Why?
|
| Kidney Failure, Chronic | 2 | 2021 | 2469 | 0.270 |
Why?
|
| Vascular Grafting | 4 | 2024 | 153 | 0.270 |
Why?
|
| Retreatment | 4 | 2017 | 600 | 0.270 |
Why?
|
| Renal Veins | 1 | 2006 | 102 | 0.260 |
Why?
|
| Arteriovenous Fistula | 2 | 2022 | 314 | 0.260 |
Why?
|
| Databases, Factual | 6 | 2023 | 8018 | 0.250 |
Why?
|
| Arteries | 3 | 2013 | 1126 | 0.250 |
Why?
|
| Prosthesis Failure | 2 | 2018 | 1206 | 0.240 |
Why?
|
| Congresses as Topic | 1 | 2009 | 804 | 0.240 |
Why?
|
| Iliac Vein | 1 | 2004 | 70 | 0.240 |
Why?
|
| Robotics | 1 | 2012 | 880 | 0.240 |
Why?
|
| Aneurysm, Ruptured | 1 | 2009 | 460 | 0.230 |
Why?
|
| Hematoma | 3 | 2017 | 769 | 0.230 |
Why?
|
| Renal Insufficiency | 2 | 2013 | 820 | 0.230 |
Why?
|
| Intraocular Pressure | 3 | 2017 | 1288 | 0.230 |
Why?
|
| Surgical Wound Infection | 5 | 2017 | 1529 | 0.230 |
Why?
|
| Viscera | 1 | 2004 | 138 | 0.230 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 1007 | 0.230 |
Why?
|
| Follow-Up Studies | 21 | 2022 | 39254 | 0.220 |
Why?
|
| American Heart Association | 4 | 2011 | 1081 | 0.220 |
Why?
|
| Visually Impaired Persons | 2 | 2016 | 78 | 0.220 |
Why?
|
| Odds Ratio | 11 | 2017 | 9712 | 0.210 |
Why?
|
| Vena Cava, Inferior | 1 | 2006 | 458 | 0.210 |
Why?
|
| Critical Illness | 7 | 2016 | 2709 | 0.210 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 2178 | 0.210 |
Why?
|
| Cost-Benefit Analysis | 7 | 2016 | 5507 | 0.210 |
Why?
|
| Atherectomy | 1 | 2022 | 40 | 0.210 |
Why?
|
| Recovery of Function | 7 | 2019 | 2982 | 0.210 |
Why?
|
| Groin | 3 | 2013 | 106 | 0.210 |
Why?
|
| Advisory Committees | 3 | 2011 | 789 | 0.210 |
Why?
|
| Clinical Competence | 3 | 2020 | 4786 | 0.210 |
Why?
|
| Carotid Arteries | 3 | 2023 | 951 | 0.200 |
Why?
|
| Retinal Diseases | 4 | 2012 | 702 | 0.200 |
Why?
|
| United States | 26 | 2024 | 72363 | 0.200 |
Why?
|
| Cognition Disorders | 1 | 2016 | 3976 | 0.190 |
Why?
|
| Boston | 11 | 2021 | 9282 | 0.190 |
Why?
|
| Age Factors | 7 | 2019 | 18415 | 0.190 |
Why?
|
| Wrist | 2 | 2021 | 219 | 0.180 |
Why?
|
| Amblyopia | 1 | 2022 | 150 | 0.180 |
Why?
|
| Glaucoma, Angle-Closure | 2 | 2015 | 191 | 0.180 |
Why?
|
| Forearm | 1 | 2023 | 429 | 0.180 |
Why?
|
| Video Games | 1 | 2022 | 190 | 0.180 |
Why?
|
| Brachial Artery | 2 | 2023 | 368 | 0.180 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2013 | 265 | 0.170 |
Why?
|
| Comorbidity | 10 | 2019 | 10552 | 0.170 |
Why?
|
| Electroporation | 2 | 2013 | 256 | 0.170 |
Why?
|
| Prospective Studies | 23 | 2022 | 54263 | 0.170 |
Why?
|
| Severity of Illness Index | 11 | 2019 | 15827 | 0.170 |
Why?
|
| Retina | 6 | 2013 | 2635 | 0.170 |
Why?
|
| Thrombolytic Therapy | 1 | 2009 | 2108 | 0.170 |
Why?
|
| Transplantation, Autologous | 8 | 2009 | 2120 | 0.170 |
Why?
|
| Laparoscopy | 1 | 2012 | 2155 | 0.170 |
Why?
|
| Angiography | 4 | 2016 | 1605 | 0.160 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 1503 | 0.160 |
Why?
|
| Eye Injuries | 2 | 2012 | 227 | 0.160 |
Why?
|
| Trabecular Meshwork | 2 | 2017 | 100 | 0.160 |
Why?
|
| Deglutition | 1 | 2019 | 208 | 0.150 |
Why?
|
| Cognition | 1 | 2016 | 6948 | 0.150 |
Why?
|
| Certification | 2 | 2014 | 423 | 0.150 |
Why?
|
| Databases as Topic | 2 | 2011 | 474 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2009 | 1819 | 0.150 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2016 | 334 | 0.140 |
Why?
|
| Ocular Hypotension | 1 | 2017 | 23 | 0.140 |
Why?
|
| Israel | 2 | 2017 | 722 | 0.140 |
Why?
|
| Seroma | 1 | 2017 | 76 | 0.140 |
Why?
|
| Aging | 1 | 2016 | 8641 | 0.140 |
Why?
|
| History, 20th Century | 2 | 2015 | 2777 | 0.130 |
Why?
|
| Tonometry, Ocular | 1 | 2017 | 235 | 0.130 |
Why?
|
| Polymers | 1 | 2023 | 1620 | 0.130 |
Why?
|
| Renal Artery | 2 | 2010 | 368 | 0.130 |
Why?
|
| Neuroprotective Agents | 3 | 2012 | 961 | 0.130 |
Why?
|
| Anastomosis, Surgical | 2 | 2012 | 983 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 695 | 0.130 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2016 | 152 | 0.130 |
Why?
|
| Cloprostenol | 1 | 2015 | 21 | 0.120 |
Why?
|
| Aorta, Abdominal | 2 | 2017 | 622 | 0.120 |
Why?
|
| Aneurysm, False | 2 | 2017 | 257 | 0.120 |
Why?
|
| Cause of Death | 2 | 2012 | 3723 | 0.120 |
Why?
|
| Health Resources | 3 | 2013 | 936 | 0.120 |
Why?
|
| Frail Elderly | 1 | 2020 | 747 | 0.120 |
Why?
|
| Comprehension | 1 | 2020 | 613 | 0.120 |
Why?
|
| Silver Compounds | 1 | 2014 | 23 | 0.120 |
Why?
|
| Intelligence Tests | 1 | 2016 | 498 | 0.120 |
Why?
|
| Refraction, Ocular | 1 | 2016 | 179 | 0.120 |
Why?
|
| Logistic Models | 6 | 2017 | 13311 | 0.120 |
Why?
|
| Eyeglasses | 1 | 2016 | 137 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2015 | 207 | 0.120 |
Why?
|
| Forecasting | 2 | 2014 | 2931 | 0.120 |
Why?
|
| Informed Consent | 1 | 2020 | 1007 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 934 | 0.110 |
Why?
|
| Decision Support Techniques | 3 | 2012 | 2002 | 0.110 |
Why?
|
| Alginates | 1 | 2014 | 247 | 0.110 |
Why?
|
| Stroke | 5 | 2014 | 9945 | 0.110 |
Why?
|
| Internship and Residency | 2 | 2014 | 5867 | 0.110 |
Why?
|
| Massachusetts | 3 | 2019 | 8805 | 0.110 |
Why?
|
| Aorta, Thoracic | 2 | 2013 | 1097 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 3967 | 0.100 |
Why?
|
| Propensity Score | 4 | 2015 | 1918 | 0.100 |
Why?
|
| Bandages | 1 | 2014 | 270 | 0.100 |
Why?
|
| Polyesters | 1 | 2014 | 372 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2015 | 720 | 0.100 |
Why?
|
| Diabetic Foot | 1 | 2016 | 381 | 0.100 |
Why?
|
| Upper Extremity | 1 | 2017 | 661 | 0.100 |
Why?
|
| Extremities | 2 | 2007 | 867 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 1500 | 0.100 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 319 | 0.100 |
Why?
|
| Polyethylenes | 1 | 2014 | 290 | 0.100 |
Why?
|
| beta Carotene | 1 | 2013 | 524 | 0.100 |
Why?
|
| Tibial Arteries | 3 | 2007 | 60 | 0.100 |
Why?
|
| Constriction, Pathologic | 2 | 2016 | 1098 | 0.100 |
Why?
|
| Foundations | 1 | 2011 | 97 | 0.100 |
Why?
|
| Life Tables | 2 | 2012 | 365 | 0.100 |
Why?
|
| Regional Blood Flow | 3 | 2017 | 1490 | 0.100 |
Why?
|
| Graft Rejection | 4 | 2012 | 4423 | 0.100 |
Why?
|
| Chronic Disease | 4 | 2015 | 9283 | 0.090 |
Why?
|
| Graft Survival | 4 | 2012 | 3793 | 0.090 |
Why?
|
| Cohort Studies | 8 | 2023 | 41317 | 0.090 |
Why?
|
| Subcutaneous Fat | 1 | 2014 | 393 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 1430 | 0.090 |
Why?
|
| Economic Competition | 1 | 2013 | 218 | 0.090 |
Why?
|
| Nursing | 1 | 2010 | 34 | 0.090 |
Why?
|
| Adult | 20 | 2019 | 219847 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2014 | 768 | 0.090 |
Why?
|
| Arteriosclerosis | 2 | 2008 | 1064 | 0.090 |
Why?
|
| Survival Rate | 6 | 2020 | 12806 | 0.090 |
Why?
|
| Blood Flow Velocity | 4 | 2022 | 1375 | 0.090 |
Why?
|
| Ophthalmic Solutions | 2 | 2009 | 305 | 0.090 |
Why?
|
| Uveal Neoplasms | 1 | 2013 | 339 | 0.090 |
Why?
|
| Disease Progression | 3 | 2017 | 13505 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2015 | 20484 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 572 | 0.090 |
Why?
|
| Patient Discharge | 2 | 2014 | 3475 | 0.090 |
Why?
|
| Sodium Chloride | 1 | 2012 | 596 | 0.090 |
Why?
|
| Treatment Failure | 3 | 2014 | 2646 | 0.090 |
Why?
|
| C-Reactive Protein | 3 | 2012 | 3822 | 0.090 |
Why?
|
| Cardiology | 2 | 2011 | 1723 | 0.090 |
Why?
|
| Societies, Medical | 3 | 2010 | 3903 | 0.090 |
Why?
|
| Retinitis Pigmentosa | 1 | 2013 | 397 | 0.080 |
Why?
|
| Probability | 2 | 2005 | 2476 | 0.080 |
Why?
|
| Iridectomy | 1 | 2009 | 48 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 822 | 0.080 |
Why?
|
| Constriction | 1 | 2009 | 171 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 25928 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2016 | 1240 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2012 | 887 | 0.080 |
Why?
|
| Endoscopy, Digestive System | 1 | 2011 | 349 | 0.080 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2012 | 1724 | 0.080 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 5884 | 0.080 |
Why?
|
| Research Report | 1 | 2011 | 370 | 0.080 |
Why?
|
| Hospitals | 2 | 2013 | 3929 | 0.080 |
Why?
|
| Drug Contamination | 1 | 2009 | 152 | 0.080 |
Why?
|
| Curriculum | 2 | 2014 | 3722 | 0.080 |
Why?
|
| Survival Analysis | 5 | 2013 | 10185 | 0.080 |
Why?
|
| Ultrasonography, Doppler | 2 | 2007 | 466 | 0.070 |
Why?
|
| Blindness | 1 | 2012 | 582 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2009 | 231 | 0.070 |
Why?
|
| Delirium | 1 | 2019 | 1651 | 0.070 |
Why?
|
| Thrombosis | 1 | 2022 | 3052 | 0.070 |
Why?
|
| Women | 1 | 2009 | 224 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2014 | 1576 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 2 | 2005 | 95 | 0.070 |
Why?
|
| Cell Communication | 1 | 2014 | 1642 | 0.070 |
Why?
|
| Adult Stem Cells | 1 | 2009 | 221 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2021 | 5420 | 0.070 |
Why?
|
| Equipment Design | 1 | 2015 | 3520 | 0.070 |
Why?
|
| Recurrence | 3 | 2016 | 8487 | 0.070 |
Why?
|
| Photoperiod | 1 | 2007 | 139 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2852 | 0.070 |
Why?
|
| Intraoperative Period | 1 | 2007 | 516 | 0.070 |
Why?
|
| Diagnostic Imaging | 3 | 2010 | 3526 | 0.060 |
Why?
|
| Lasers | 1 | 2010 | 952 | 0.060 |
Why?
|
| E2F Transcription Factors | 1 | 2006 | 269 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2017 | 10340 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2015 | 2494 | 0.060 |
Why?
|
| Dementia | 1 | 2019 | 2638 | 0.060 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 1118 | 0.060 |
Why?
|
| Anesthesia | 1 | 2016 | 1584 | 0.060 |
Why?
|
| Knee Joint | 1 | 2013 | 1662 | 0.060 |
Why?
|
| Myopia | 1 | 2007 | 245 | 0.060 |
Why?
|
| Vitamins | 1 | 2013 | 1635 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 546 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2024 | 2255 | 0.060 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2005 | 90 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2014 | 2273 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2005 | 178 | 0.060 |
Why?
|
| Aneurysm, Infected | 1 | 2005 | 81 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 2 | 2013 | 1822 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2641 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2016 | 6210 | 0.060 |
Why?
|
| Incidence | 5 | 2016 | 21378 | 0.060 |
Why?
|
| Postoperative Hemorrhage | 1 | 2007 | 422 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2011 | 1130 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2009 | 707 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 2 | 2023 | 718 | 0.060 |
Why?
|
| Parturition | 1 | 2007 | 445 | 0.060 |
Why?
|
| General Surgery | 1 | 2015 | 1681 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2010 | 1045 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 819 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2730 | 0.050 |
Why?
|
| Ankle Brachial Index | 2 | 2016 | 163 | 0.050 |
Why?
|
| Vena Cava Filters | 1 | 2006 | 261 | 0.050 |
Why?
|
| Quinoxalines | 1 | 2005 | 297 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7016 | 0.050 |
Why?
|
| Radiography | 2 | 2004 | 6965 | 0.050 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2005 | 250 | 0.050 |
Why?
|
| Sensory Deprivation | 1 | 2022 | 106 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1335 | 0.050 |
Why?
|
| Mesenteric Arteries | 1 | 2002 | 178 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 3335 | 0.050 |
Why?
|
| Survivors | 1 | 2013 | 2367 | 0.050 |
Why?
|
| Endarterectomy | 1 | 2002 | 195 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4044 | 0.050 |
Why?
|
| Choroidal Neovascularization | 1 | 2005 | 357 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2414 | 0.050 |
Why?
|
| Seasons | 1 | 2007 | 1523 | 0.050 |
Why?
|
| Embolism | 1 | 2005 | 408 | 0.050 |
Why?
|
| Aortic Rupture | 1 | 2004 | 313 | 0.050 |
Why?
|
| Predictive Value of Tests | 5 | 2016 | 15273 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2008 | 3333 | 0.050 |
Why?
|
| Vision, Binocular | 1 | 2022 | 225 | 0.050 |
Why?
|
| Health Status | 1 | 2014 | 4081 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 6830 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 7803 | 0.040 |
Why?
|
| Oligonucleotides | 3 | 2008 | 588 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3840 | 0.040 |
Why?
|
| Lasers, Gas | 2 | 2012 | 94 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 2 | 2017 | 1723 | 0.040 |
Why?
|
| Quality of Life | 4 | 2016 | 13300 | 0.040 |
Why?
|
| Ligation | 1 | 2021 | 448 | 0.040 |
Why?
|
| Inflammation Mediators | 3 | 2014 | 1882 | 0.040 |
Why?
|
| Intravitreal Injections | 2 | 2012 | 383 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3870 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2017 | 12901 | 0.040 |
Why?
|
| Linear Models | 3 | 2014 | 5876 | 0.040 |
Why?
|
| Retinal Vessels | 1 | 2005 | 836 | 0.040 |
Why?
|
| Clinical Trials as Topic | 3 | 2011 | 8058 | 0.040 |
Why?
|
| Bioprosthesis | 1 | 2023 | 599 | 0.040 |
Why?
|
| Administration, Topical | 2 | 2014 | 697 | 0.040 |
Why?
|
| Electroretinography | 2 | 2013 | 518 | 0.040 |
Why?
|
| Acute Disease | 1 | 2009 | 7268 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6457 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4409 | 0.040 |
Why?
|
| Heart Failure | 3 | 2014 | 11835 | 0.040 |
Why?
|
| Prevalence | 4 | 2019 | 15687 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 1484 | 0.040 |
Why?
|
| Cattle | 1 | 2023 | 3847 | 0.040 |
Why?
|
| Double-Blind Method | 5 | 2013 | 12412 | 0.040 |
Why?
|
| Radiology | 1 | 2010 | 2103 | 0.030 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 33 | 0.030 |
Why?
|
| Medical Errors | 1 | 2005 | 1255 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2017 | 516 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2017 | 217 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2011 | 3524 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4361 | 0.030 |
Why?
|
| Skilled Nursing Facilities | 1 | 2019 | 398 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2014 | 19 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2004 | 1666 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2006 | 1290 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 3381 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5695 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 2129 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2014 | 145 | 0.030 |
Why?
|
| Sex Factors | 3 | 2017 | 10530 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2014 | 150 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10757 | 0.030 |
Why?
|
| Young Adult | 4 | 2014 | 58673 | 0.030 |
Why?
|
| North America | 2 | 2007 | 1282 | 0.030 |
Why?
|
| Chlorophyta | 1 | 2013 | 16 | 0.030 |
Why?
|
| Rats | 4 | 2012 | 23695 | 0.030 |
Why?
|
| Eye Enucleation | 1 | 2013 | 128 | 0.030 |
Why?
|
| Powders | 1 | 2013 | 80 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7468 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2014 | 4169 | 0.030 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 218 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 36247 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 1399 | 0.030 |
Why?
|
| Texas | 1 | 2014 | 401 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 936 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2014 | 422 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 15766 | 0.030 |
Why?
|
| Elasticity | 2 | 2006 | 652 | 0.030 |
Why?
|
| Edema | 1 | 2017 | 772 | 0.030 |
Why?
|
| Oxygen | 1 | 2005 | 4189 | 0.030 |
Why?
|
| Guided Tissue Regeneration | 1 | 2013 | 88 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2013 | 4044 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2007 | 2296 | 0.030 |
Why?
|
| Blood Donors | 1 | 2014 | 343 | 0.030 |
Why?
|
| Dark Adaptation | 1 | 2013 | 221 | 0.030 |
Why?
|
| Hindlimb | 1 | 2014 | 510 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 463 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2007 | 4896 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 2 | 2012 | 2178 | 0.020 |
Why?
|
| Cardiovascular Agents | 2 | 2007 | 864 | 0.020 |
Why?
|
| Cost Savings | 1 | 2016 | 920 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2013 | 5201 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1340 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2013 | 249 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 2311 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2014 | 1446 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2010 | 317 | 0.020 |
Why?
|
| New England | 1 | 2013 | 1045 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2010 | 210 | 0.020 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2009 | 34 | 0.020 |
Why?
|
| Eye | 1 | 2013 | 710 | 0.020 |
Why?
|
| Vascular Diseases | 2 | 2010 | 1180 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 18134 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 328 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 4923 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 1388 | 0.020 |
Why?
|
| Iris | 1 | 2009 | 231 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 13967 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 730 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2016 | 1957 | 0.020 |
Why?
|
| Prognosis | 3 | 2016 | 29636 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2009 | 245 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3605 | 0.020 |
Why?
|
| Ocular Hypertension | 1 | 2009 | 206 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.020 |
Why?
|
| Animals | 6 | 2023 | 167940 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2009 | 296 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2061 | 0.020 |
Why?
|
| Light | 1 | 2013 | 1344 | 0.020 |
Why?
|
| Adiposity | 1 | 2017 | 1851 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 2295 | 0.020 |
Why?
|
| Hospitalization | 1 | 2006 | 10761 | 0.020 |
Why?
|
| Visual Fields | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2014 | 18968 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 3201 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2893 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 3605 | 0.020 |
Why?
|
| Phenotype | 2 | 2014 | 16543 | 0.020 |
Why?
|
| Cataract | 1 | 2012 | 828 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 2007 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 881 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2006 | 2094 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 2063 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2006 | 203 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2010 | 1045 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 2633 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 2009 | 646 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 2509 | 0.010 |
Why?
|
| Macular Degeneration | 1 | 2012 | 1003 | 0.010 |
Why?
|
| Benchmarking | 1 | 2010 | 1043 | 0.010 |
Why?
|
| Adolescent | 4 | 2014 | 87747 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2010 | 920 | 0.010 |
Why?
|
| Minority Groups | 1 | 2010 | 1199 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2716 | 0.010 |
Why?
|
| Hand | 1 | 2008 | 903 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 1520 | 0.010 |
Why?
|
| Research Design | 2 | 2009 | 6181 | 0.010 |
Why?
|
| Temperature | 1 | 2009 | 2221 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 2012 | 1268 | 0.010 |
Why?
|
| Time | 1 | 2004 | 545 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2004 | 239 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 1256 | 0.010 |
Why?
|
| Glaucoma | 1 | 2012 | 1183 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2006 | 1821 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2011 | 1940 | 0.010 |
Why?
|
| Oximetry | 1 | 2005 | 461 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5784 | 0.010 |
Why?
|
| Medicare | 1 | 2019 | 6771 | 0.010 |
Why?
|
| Creatinine | 1 | 2007 | 1906 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5301 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3336 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2010 | 2058 | 0.010 |
Why?
|
| Endocarditis | 1 | 2005 | 351 | 0.010 |
Why?
|
| Catheterization | 1 | 2006 | 1432 | 0.010 |
Why?
|
| Child | 2 | 2022 | 79758 | 0.010 |
Why?
|
| Surgical Instruments | 1 | 2002 | 385 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5745 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2012 | 3530 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4560 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4920 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3696 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2010 | 2500 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20048 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2363 | 0.010 |
Why?
|
| Medicaid | 1 | 2010 | 2811 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 2878 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 4223 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 3870 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 14482 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 1907 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2009 | 5513 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2010 | 8523 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2002 | 1342 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2007 | 5960 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2005 | 1583 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8551 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8553 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 22041 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23363 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17766 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 36030 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 42034 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 81216 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 15740 | 0.000 |
Why?
|